Literature DB >> 6349552

Binding of isolated rheumatoid factors to histone proteins and basic polycations.

R N Hobbs, D J Lea, K K Phua, P M Johnson.   

Abstract

A fluorimetric immunoassay has been used to assess reactivity of rheumatoid factor (RF) with both histone proteins and other basic polycations (poly-L-lysine, poly-L-ornithine, and protamine) bound to an immobilised tyrosine-glutamic acid polyanionic copolymer. Isolated RF preparations can bind to histone proteins in this assay, notably to H3 and H4 histones, and this activity was always masked in the original whole seropositive sera. Binding of isolated RF was often noted also to the other large-molecular-weight basic polycations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6349552      PMCID: PMC1001258          DOI: 10.1136/ard.42.4.435

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  10 in total

1.  Acidic polypeptides can assemble both histones and chromatin in vitro at physiological ionic strength.

Authors:  A Stein; J P Whitlock; M Bina
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

2.  Monoclonal and polyclonal gamma M rheumatoid factors with anti-di- and anti-trinitrophenyl activity.

Authors:  K Hannestad
Journal:  Clin Exp Immunol       Date:  1969-05       Impact factor: 4.330

3.  The isolation and purification of histones.

Authors:  E W Johns
Journal:  Methods Cell Biol       Date:  1977       Impact factor: 1.441

4.  Certain rheumatoid factors react with nucleosomes.

Authors:  K Hannestad; B D Stollar
Journal:  Nature       Date:  1978-10-19       Impact factor: 49.962

5.  Nucleosomes are assembled by an acidic protein which binds histones and transfers them to DNA.

Authors:  R A Laskey; B M Honda; A D Mills; J T Finch
Journal:  Nature       Date:  1978-10-05       Impact factor: 49.962

6.  IgM-rheumatoid factors cross-reactive with IgG and a cell nuclear antigen: apparent 'masking' in original serum.

Authors:  P M Johnson
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

7.  Estimation of IgM rheumatoid factors by fluorimetry.

Authors:  D J Lea; D J Ward
Journal:  Ann Rheum Dis       Date:  1978-06       Impact factor: 19.103

8.  Certain rheumatoid factors react with both IgG and an antigen associated with cell nuclei.

Authors:  K Hannestad
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

9.  IgM-rheumatoid factors cross-reactive with IgG and a cell nuclear antigen: immunopathological implications?

Authors:  P M Johnson
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

10.  Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype.

Authors:  V Agnello; A Arbetter; G Ibanez de Kasep; R Powell; E M Tan; F Joslin
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

  10 in total
  10 in total

1.  Polyclonal human rheumatoid factors cross-reacting with histone H3: characterization of an idiotope on the H3 binding site.

Authors:  T Martin; A M Knapp; S Muller; J L Pasquali
Journal:  J Clin Immunol       Date:  1990-07       Impact factor: 8.317

2.  Characterisation of non-histone nuclear proteins cross reactive with purified rheumatoid factors.

Authors:  J C Mason; P J Venables; P R Smith; R N Maini
Journal:  Ann Rheum Dis       Date:  1985-05       Impact factor: 19.103

3.  Multiple autoantigen binding capabilities of mouse monoclonal antibodies selected for rheumatoid factor activity.

Authors:  R L Rubin; R S Balderas; E M Tan; F J Dixon; A N Theofilopoulos
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

4.  Antibodies to the five histones and poly(adenosine diphosphate-ribose) in drug induced lupus: implications for pathogenesis.

Authors:  R N Hobbs; A L Clayton; R M Bernstein
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

5.  Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex.

Authors:  R L Rubin; S A Bell; R W Burlingame
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

6.  Human-human hybridoma autoantibodies with both anti-DNA and rheumatoid factor activities.

Authors:  J Rauch; H Tannenbaum; K Straaton; H Massicotte; J Wild
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

7.  Antibody to streptococcal cell wall peptidoglycan-polysaccharide polymers in seropositive and seronegative rheumatic disease.

Authors:  P M Johnson; K K Phua; H R Perkins; C A Hart; R C Bucknall
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

8.  Human monoclonal rheumatoid factors: incidence of cross-reactions with tissue components and correlation with VH gene usage.

Authors:  S J Thorpe; M Børretzen; S W Bailey; I Randen; J B Natvig; K M Thompson
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

9.  Cross-reactive rheumatoid factors in rheumatoid arthritis with extra-articular disease.

Authors:  M Kinoshita; S Aotsuka; R Yokohari
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

10.  An idiotypic complementarity between rheumatoid factor and anti-peptidoglycan antibodies?

Authors:  P M Johnson; K K Phua; H B Evans
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.